PED.: Implementation of a diagnostic test for clinical evaluation of patients with lung cancer based on proteomic analysis of immune characteristics and microenvironment of the tumour. (Q2878694): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: co-financing rate (P837): 40.0 percentage) |
(Changed an Item: Import item from Portugal) |
||||||||||
Property / budget | Property / budget | ||||||||||
| 239,769.35 Euro
| ||||||||||
Property / EU contribution | Property / EU contribution | ||||||||||
| 95,907.74 Euro
| ||||||||||
Property / priority axis | |||||||||||
Property / priority axis: Strengthening research, technological development and innovation / rank | |||||||||||
Normal rank | |||||||||||
Property / co-financing rate | |||||||||||
40.0 percent
| |||||||||||
Property / co-financing rate: 40.0 percent / rank | |||||||||||
Normal rank |
Revision as of 17:57, 4 November 2022
Project Q2878694 in Portugal
Language | Label | Description | Also known as |
---|---|---|---|
English | PED.: Implementation of a diagnostic test for clinical evaluation of patients with lung cancer based on proteomic analysis of immune characteristics and microenvironment of the tumour. |
Project Q2878694 in Portugal |
Statements
95,907.74 Euro
0 references
239,769.35 Euro
0 references
40.0 percent
0 references
1 October 2018
0 references
30 September 2021
0 references
UNIVERSIDADE NOVA DE LISBOA
0 references
Q2993197 (Deleted Item)
0 references
Lisboa
0 references
Identifiers
LISBOA-01-0145-FEDER-030088
0 references